Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Unraveling resistance to trastuzumab (Herceptin): insulin-like growth factor-I receptor, a new suspect.

× No keyword cloud information.

17 in total

Review 1. Pertuzumab: in the first-line treatment of HER2-positive metastatic breast cancer.

Authors: Gillian M Keating
Journal: Drugs Date: 2012-02-12 Impact factor: 9.546

2. Therapeutic destruction of insulin receptor substrates for cancer treatment.

Authors: Hadas Reuveni; Efrat Flashner-Abramson; Lilach Steiner; Kirill Makedonski; Renduo Song; Alexei Shir; Meenhard Herlyn; Menashe Bar-Eli; Alexander Levitzki
Journal: Cancer Res Date: 2013-05-07 Impact factor: 12.701

Review 3. Targeting insulin and insulin-like growth factor signaling in breast cancer.

Authors: Yuzhe Yang; Douglas Yee
Journal: J Mammary Gland Biol Neoplasia Date: 2012-10-10 Impact factor: 2.673

4. Involvement of insulin receptor substrate 2 in mammary tumor metastasis.

Authors: Julie A Nagle; Zhefu Ma; Maura A Byrne; Morris F White; Leslie M Shaw
Journal: Mol Cell Biol Date: 2004-11 Impact factor: 4.272

Review 5. Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach.

Authors: Rongshi Li; Alan Pourpak; Stephan W Morris
Journal: J Med Chem Date: 2009-08-27 Impact factor: 7.446

6. siRNA mediated the type 1 insulin-like growth factor receptor and epidermal growth factor receptor silencing induces chemosensitization of liver cancer cells.

Authors: Jian Niu; Xiang-Nong Li; Haixin Qian; Zeguang Han
Journal: J Cancer Res Clin Oncol Date: 2007-09-28 Impact factor: 4.553

7. Nordihydroguaiaretic acid, a cytotoxic insulin-like growth factor-I receptor/HER2 inhibitor in trastuzumab-resistant breast cancer.

Authors: Danica L Rowe; Tuba Ozbay; Laura M Bender; Rita Nahta
Journal: Mol Cancer Ther Date: 2008-07 Impact factor: 6.261

8. Establishment and characterization of a model of acquired resistance to epidermal growth factor receptor targeting agents in human cancer cells.

Authors: Sergio Benavente; Shyhmin Huang; Eric A Armstrong; Alexander Chi; Kun-Tai Hsu; Deric L Wheeler; Paul M Harari
Journal: Clin Cancer Res Date: 2009-02-03 Impact factor: 12.531

9. Alternative splicing enriched cDNA libraries identify breast cancer-associated transcripts.

Authors: Elisa N Ferreira; Maria C R Rangel; Pedro F Galante; Jorge E de Souza; Gustavo C Molina; Sandro J de Souza; Dirce M Carraro
Journal: BMC Genomics Date: 2010-12-22 Impact factor: 3.969

10. Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605.

Authors: William N Pappano; Paul M Jung; Jonathan A Meulbroek; Yi-Chun Wang; Robert D Hubbard; Qian Zhang; Meagan M Grudzien; Niru B Soni; Eric F Johnson; George S Sheppard; Cherrie Donawho; Fritz G Buchanan; Steven K Davidsen; Randy L Bell; Jieyi Wang
Journal: BMC Cancer Date: 2009-09-04 Impact factor: 4.430